| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 63,392 | 63,272 | 65,284 | 63,186 | | Cost of Revenue | 27,007 | 26,771 | 26,749 | 25,960 | | | Gross Profit | 36,385 | 36,501 | 38,535 | 37,226 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,377 | 6,716 | 5,992 | 5,560 | | Non Recurring |
-
|
-
|
-
| 13,171 | | Others | 15,841 | 15,915 | 16,204 | 16,471 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,167 | 13,870 | 16,339 | 2,024 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 18,361 | 13,870 | 16,339 | 2,024 | | Interest Expense | 15,948 | 15,574 | 15,080 | 16,311 | | Income Before Tax | 2,413 | (1,704) | 1,259 | (14,287) | | Income Tax Expense | 103 | 146 | 133 | 302 | | Minority Interest |
-
| 104 | (104) | (1,441) | | | | Net Income From Continuing Ops | (2,738) | (2,263) | 1,049 | (18,492) | | | Non-recurring Events | | Discontinued Operations | 177 | (160) | (172) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,871) | (2,423) | 877 | (18,492) | | Preferred Stock And Other Adjustments | (164) | 164 |
-
|
-
| | | Net Income Applicable To Common Shares | ($2,035) | ($2,259) | $877 | ($18,492) |
|
0.51% Nasdaq 
Income Statement
